Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9296 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8929 |
High Similarity |
NPD1510 |
Phase 2 |
0.8873 |
High Similarity |
NPD1549 |
Phase 2 |
0.8803 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8803 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8777 |
High Similarity |
NPD1240 |
Approved |
0.8767 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD6801 |
Discontinued |
0.8725 |
High Similarity |
NPD4380 |
Phase 2 |
0.8652 |
High Similarity |
NPD1607 |
Approved |
0.8627 |
High Similarity |
NPD7075 |
Discontinued |
0.8601 |
High Similarity |
NPD2796 |
Approved |
0.8581 |
High Similarity |
NPD1512 |
Approved |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8552 |
High Similarity |
NPD2800 |
Approved |
0.8523 |
High Similarity |
NPD920 |
Approved |
0.8446 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8446 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8421 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8387 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8377 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8356 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8312 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8299 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8219 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8138 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8121 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8113 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8113 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD919 |
Approved |
0.8089 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8026 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8026 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8026 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8026 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7975 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7911 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7831 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7801 |
Intermediate Similarity |
NPD9717 |
Approved |
0.78 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7762 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD943 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3226 |
Approved |
0.759 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7584 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7571 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7571 |
Intermediate Similarity |
NPD9545 |
Approved |
0.756 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6100 |
Approved |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7466 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7425 |
Intermediate Similarity |
NPD2403 |
Approved |
0.741 |
Intermediate Similarity |
NPD5710 |
Approved |
0.741 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD411 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.736 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7243 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7104 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7067 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD4749 |
Approved |
0.702 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD1653 |
Approved |
0.6989 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD7698 |
Approved |
0.6989 |
Remote Similarity |
NPD8312 |
Approved |
0.6989 |
Remote Similarity |
NPD8313 |
Approved |
0.6989 |
Remote Similarity |
NPD7697 |
Approved |
0.6989 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6986 |
Remote Similarity |
NPD17 |
Approved |
0.6983 |
Remote Similarity |
NPD4287 |
Approved |
0.6974 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.697 |
Remote Similarity |
NPD5890 |
Approved |
0.697 |
Remote Similarity |
NPD5889 |
Approved |
0.6966
|
Remote Similarity |
NPD8150 |
Discontinued |